Narinder Nangia

Narsoplimab, a Mannan-Binding Lectin-Associated Serine Protease-2 Inhibitor, for the Treatment of Adult Hematopoietic Stem-Cell Transplantation–Associated Thrombotic Microangiopathy

Samer K. Khaled, Kathleen Claes, Yeow Tee Goh et al. · Journal of Clinical Oncology · 2022 · 87 citations · Full text

Effects of valdecoxib in the treatment of chronic low back pain: results of a randomized, placebo-controlled trial

Teresa L. Coats, David Borenstein, Narinder Nangia et al. · Clinical Therapeutics · 2004 · 78 citations

Pain Therapy, Health Sciences, Pain Medicine +7

Opioid system modulation with buprenorphine/samidorphan combination for major depressive disorder: two randomized controlled studies

Maurizio Fava, Michael E. Thase, Madhukar H. Trivedi et al. · Molecular Psychiatry · 2018 · 77 citations · Full text

Diroximel fumarate (DRF) in patients with relapsing–remitting multiple sclerosis: Interim safety and efficacy results from the phase 3 EVOLVE-MS-1 study

Robert T. Naismith, Jerry S. Wolinsky, Annette Wundes et al. · Multiple Sclerosis Journal · 2019 · 62 citations · Full text

Outpatient transition to extended-release injectable naltrexone for patients with opioid use disorder: A phase 3 randomized trial

Adam Bisaga, Paolo Mannelli, Miao Yu et al. · Drug and Alcohol Dependence · 2018 · 47 citations · Full text